Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
clinical trials
fda
life sciences
national blog main
biotech
boston blog main
national top stories
new york top stories
boston top stories
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
abbvie
acorda therapeutics
aimmune therapeutics
allergy
alprazolam
amgen
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
archive
billy dunn
biogen
boulder/denver blog main
boulder/denver top stories
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
dalfampridine
daniel edelman
detroit blog main
detroit top stories
drug enforcement administration
drug prices
What
drug
5
×
fda
friday
5
×
approved
new
approval
late
oral
patients
therapy
won
acorda
acute
addresses
administration
agency
aimmune
allergy
atrophy
avoid
awarded
causes
collectively
condition
cope
daily
decades
developed
disease
eli
episodes
evrysdi
food
gets
giant
giving
green
help
home
homemade
Language
unset
Current search:
friday
×
photo
×
drug
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@slashgear.com
4 years ago
FDA issues strong warning to avoid all THC and ‘street’ vapes
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms